A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

Completed

• Conditions: COPD; Chronic Diseases

• Registration Number: NCT00772733
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team

Detailed Description

Not available

Study Timeline

• Study Start: 2008-10
• Study First Submitted: 2008-10-14
• Study First Submitted QC: 2008-10-14
• Study First Posted: 2008-10-15
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Status Verified: 2011-02
• Last Update Submitted: 2011-02-21
• Last Update Posted: 2011-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 936

Inclusion Criteria

• COPD diagnose, verified by spirometry
• Having given informed consent

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Control visits at General practitioners	6-12 months
Lung function measured by spirometry	6-12 months

Secondary Outcome Measures

Name	Time	Method
Smoking status	6-12 months
Dyspnoea on MRC scale	6-12 months
Rehabilitation completed in the municipality rehabilitation team	6-12 months

Trial Locations

Locations (1)

Research Site; 🇩🇰 Viborg, Denmark